Halo Collective Inc

PINK:HCANF USA Drug Manufacturers - Specialty & Generic
Market Cap
$15.08K
Market Cap Rank
#44326 Global
#14069 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$6090.00
About

Halo Collective Inc., together with its subsidiaries, engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States. The company offers concentrates, such as shatter, sauce, live resin, badder, hash, rosin, and THC-A crystals; and oils in both in raw and distillated form in various strains and flavors, as well as strain… Read more

Halo Collective Inc (HCANF) - Net Assets

Latest net assets as of June 2023: $19.74 Million USD

Based on the latest financial reports, Halo Collective Inc (HCANF) has net assets worth $19.74 Million USD as of June 2023.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($44.19 Million) and total liabilities ($24.46 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $19.74 Million
% of Total Assets 44.66%
Annual Growth Rate 17.61%
5-Year Change 99.47%
10-Year Change 752.24%
Growth Volatility 593.06

Halo Collective Inc - Net Assets Trend (1999–2022)

This chart illustrates how Halo Collective Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Halo Collective Inc (1999–2022)

The table below shows the annual net assets of Halo Collective Inc from 1999 to 2022.

Year Net Assets Change
2022-12-31 $29.43 Million -55.71%
2021-12-31 $66.46 Million +11.47%
2020-12-31 $59.62 Million +145.43%
2019-12-31 $24.29 Million +64.63%
2018-12-31 $14.76 Million +2737.01%
2017-12-31 $520.13K -52.33%
2016-12-31 $1.09 Million +0.00%
2015-12-31 $1.09 Million -64.58%
2014-12-31 $3.08 Million -10.82%
2013-12-31 $3.45 Million -91.60%
2012-12-31 $41.14 Million -3.25%
2011-12-31 $42.52 Million -10.92%
2010-12-31 $47.73 Million +239.95%
2009-12-31 $14.04 Million +56.60%
2008-12-31 $8.97 Million -39.98%
2007-12-31 $14.94 Million +51.65%
2006-12-31 $9.85 Million -15.26%
2005-12-31 $11.63 Million +1105.79%
2004-12-31 $964.15K +123.11%
2003-12-31 $432.14K +18.76%
2002-12-31 $363.89K -3.02%
2001-12-31 $375.21K -7.69%
2000-12-31 $406.46K -42.35%
1999-12-31 $705.09K --

Equity Component Analysis

This analysis shows how different components contribute to Halo Collective Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 26144735392.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2022)

Component Amount Percentage
Common Stock $277.82 Million 852.75%
Other Comprehensive Income $17.71 Million 54.36%
Total Equity $32.58 Million 100.00%

Halo Collective Inc Competitors by Market Cap

The table below lists competitors of Halo Collective Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Halo Collective Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2021 to 2022, total equity changed from 68,752,384 to 32,579,136, a change of -36,173,248 (-52.6%).
  • Net loss of 83,869,000 reduced equity.
  • New share issuances of 7,905,601 increased equity.
  • Other comprehensive income decreased equity by 2,622,336.
  • Other factors increased equity by 42,412,487.

Equity Change Factors (2021 to 2022)

Factor Impact Contribution
Net Income $-83.87 Million -257.43%
Share Issuances $7.91 Million +24.27%
Other Comprehensive Income $-2.62 Million -8.05%
Other Changes $42.41 Million +130.18%
Total Change $- -52.61%

Book Value vs Market Value Analysis

This analysis compares Halo Collective Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.00x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1999-12-31 $1401.76 $0.00 x
2000-12-31 $58065.43 $0.00 x
2001-12-31 $53601.43 $0.00 x
2002-12-31 $723.44 $0.00 x
2003-12-31 $30867.14 $0.00 x
2004-12-31 $37082.62 $0.00 x
2005-12-31 $5054.61 $0.00 x
2006-12-31 $147029.45 $0.00 x
2007-12-31 $2814.51 $0.00 x
2008-12-31 $1376.86 $0.00 x
2009-12-31 $1292.98 $0.00 x
2010-12-31 $2620.51 $0.00 x
2011-12-31 $1448.94 $0.00 x
2012-12-31 $1292.97 $0.00 x
2013-12-31 $4983.70 $0.00 x
2014-12-31 $4444.65 $0.00 x
2015-12-31 $1227.12 $0.00 x
2016-12-31 $1227.12 $0.00 x
2017-12-31 $634.10 $0.00 x
2018-12-31 $2360.98 $0.00 x
2019-12-31 $61.82 $0.00 x
2020-12-31 $52.67 $0.00 x
2021-12-31 $59.84 $0.00 x
2022-12-31 $4.10 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Halo Collective Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -257.43%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -341.78%
  • • Asset Turnover: 0.43x
  • • Equity Multiplier: 1.75x
  • Recent ROE (-257.43%) is below the historical average (-97.43%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1999 -35.05% 0.00% 0.00x 1.01x $-317.66K
2000 -69.76% -794.63% 0.09x 1.02x $-324.20K
2001 -8.11% -225.01% 0.04x 1.01x $-67.97K
2002 -16.09% -1858.50% 0.01x 1.03x $-94.93K
2003 -102.69% -9774.56% 0.01x 1.04x $-486.98K
2004 -67.33% -7651.75% 0.01x 1.02x $-745.59K
2005 -29.80% 0.00% 0.00x 1.26x $-4.63 Million
2006 -41.53% 0.00% 0.00x 1.23x $-5.08 Million
2007 -17.02% 0.00% 0.00x 1.24x $-4.04 Million
2008 -60.75% 0.00% 0.00x 1.07x $-6.34 Million
2009 -3.50% 0.00% 0.00x 1.02x $-1.90 Million
2010 -10.17% 0.00% 0.00x 1.07x $-9.63 Million
2011 -8.61% 0.00% 0.00x 1.04x $-7.91 Million
2012 -8.19% 0.00% 0.00x 1.05x $-7.48 Million
2013 -1173.72% 0.00% 0.00x 3.21x $-40.88 Million
2014 3.63% 0.00% 0.00x 1.39x $-196.28K
2015 121.98% 0.00% 0.00x 1.11x $1.23 Million
2016 26.62% 5.77% 4.16x 1.11x $182.99K
2017 -167.55% -9.52% 0.98x 17.98x $-1.01 Million
2018 -92.96% -125.88% 0.56x 1.31x $-15.19 Million
2019 -113.69% -98.11% 0.67x 1.73x $-30.05 Million
2020 -69.08% -190.31% 0.25x 1.47x $-47.15 Million
2021 -137.61% -261.51% 0.35x 1.52x $-101.49 Million
2022 -257.43% -341.78% 0.43x 1.75x $-87.13 Million

Industry Comparison

This section compares Halo Collective Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Halo Collective Inc (HCANF) $19.74 Million -35.05% 1.24x $14.93K
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million